HRS4R
Vull donar

DAVID CRUZ GARCIA

Firma
DAVID CRUZ-GARCIA
Posició
Investigador/a Pre-doctoral – R1
Investigadors/es Pre-doctorals – R1

Projectes

Codi oficial: La Marató 201906-30 Data inici: 30/09/2020 Data fi: 29/09/2023 Investigador/a principal: JOAQUIM BOSCH BARRERA Organisme finançador: FUNDACIO LA MARATO TV3 Ajuda: 109,562.50 €

Publicacions

Díaz-Santa J, Rodríguez-Romanos R, Osca G, Pratcorona M, Garrido A, Coll R, Moret C, Escoda L, Tormo M, Heras I, Arnan M, Vives S, Salamero O, Lloveras N, Bargay J, Sampol A, Cruz D, Garcia A, Quiñones T, Esteve J, Sierra J, Gallardo D, on the behalf of CETLAM Group

UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy.

Leukemia, 2020, 34, 2925-2933 dx.doi.org/10.1038/s41375-020-0784-2

Cruz D, Costa P, Sagüés M

Meningeal cryptococcosis in a patient with angioimmunoblastic lymphoma treated with alemtuzumab.

MEDICINA CLINICA, 2019, 152 dx.doi.org/10.1016/j.medcli.2018.05.030

Formulari de contacte

Coneix l’IDIBGI!

menu